
Follow the link for the full media story
Follow the link for the full media story
Prostate cancer patients whose cancer has spread have a game-changing new option for treatment.
May 12, 2025
BAMF Health dosed the first patient in the U.S. for Radiopharm Theranostics’ Phase 2b imaging study of 18F-RAD101 in suspected recurrent brain metastasis.
April 28, 2025
This non-invasive clinical trial aims to understand the prevalence of a specific biomarker in HR-/HER2+ breast cancer.
April 24, 2025